| value | count | graph |
|---|
| Body weight QTL 45 | 2 | ************************************************************ |
| Estrogen-dependent pituitary mass QTL 11 | 2 | ************************************************************ |
| Blood pressure QTL cluster 2 | 2 | ************************************************************ |
| Ventral root avulsion QTL 1 | 2 | ************************************************************ |
| Body weight QTL 6 | 1 | ****************************** |
| Blood pressure QTL 32 | 1 | ****************************** |
| Body weight QTL 28 | 1 | ****************************** |
| Blood pressure QTL 190 | 1 | ****************************** |
| Blood pressure QTL 117 | 1 | ****************************** |
| Collagen induced arthritis QTL 16 | 1 | ****************************** |
| Despair related QTL 5 | 1 | ****************************** |
| Blood pressure QTL 185 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 34 | 1 | ****************************** |
| Blood pressure QTL 62 | 1 | ****************************** |
| Blood pressure QTL 244 | 1 | ****************************** |
| Cardiac mass QTL 3 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 44 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL z | 1 | ****************************** |
| Body weight QTL 48 | 1 | ****************************** |
| Kidney mass QTL 6 | 1 | ****************************** |
| Pristane induced arthritis QTL 19 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 8 | 1 | ****************************** |
| Kidney mass QTL 22 | 1 | ****************************** |
| Kidney mass QTL 8 | 1 | ****************************** |
| Renal damage susceptibility QTL 2 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 24 | 1 | ****************************** |
| Serum triglyceride level QTL 17 | 1 | ****************************** |
| Blood pressure QTL 237 | 1 | ****************************** |
| Glomerulus QTL 2 | 1 | ****************************** |
| Blood pressure QTL 72 | 1 | ****************************** |
| Alcohol sensitivity QTL 1 | 1 | ****************************** |
| Urinary albumin excretion QTL 28 | 1 | ****************************** |
| Urinary albumin excretion QTL 13 | 1 | ****************************** |
| Renal disease susceptibility QTL 4 | 1 | ****************************** |
| Bone structure and strength QTL 4 | 1 | ****************************** |
| Heart rate QTL 13 | 1 | ****************************** |
| Blood pressure QTL 147 | 1 | ****************************** |
| Body weight QTL5 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 5 | 1 | ****************************** |
| Schwannoma susceptibility QTL 4 | 1 | ****************************** |
| Blood pressure QTL 235 | 1 | ****************************** |
| Blood pressure QTL 154 | 1 | ****************************** |
| Collagen induced arthritis QTL 23 | 1 | ****************************** |
| Blood pressure QTL 25 | 1 | ****************************** |
| Urinary albumin excretion QTL 30 | 1 | ****************************** |
| Cardiac mass QTL 31 | 1 | ****************************** |
| Mammary tumor resistance QTL 4 | 1 | ****************************** |
| Blood pressure QTL 103 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 4 | 1 | ****************************** |
| Serum cholesterol level QTL 53 | 1 | ****************************** |
| Renal function QTL 31 | 1 | ****************************** |
| Saccharine consumption QTL 4 | 1 | ****************************** |
| Blood pressure QTL 74 | 1 | ****************************** |
| Blood pressure QTL 1 | 1 | ****************************** |
| Spike wave discharge measurement QTL 3 | 1 | ****************************** |
| Cold stress response QTL 1 | 1 | ****************************** |
| Pristane induced arthritis QTL 21 | 1 | ****************************** |
| Oil induced arthritis QTL 5 | 1 | ****************************** |
| Body weight QTL 19 | 1 | ****************************** |
| Vascular neointimal growth QTL 3 | 1 | ****************************** |
| Serum triglyceride level QTL 11 | 1 | ****************************** |
| Anxiety related response QTL 5 | 1 | ****************************** |
| Blood pressure QTL 133 | 1 | ****************************** |
| Collagen induced arthritis QTL 3 | 1 | ****************************** |
| Bone structure and strength QTL 9 | 1 | ****************************** |
| Serum leptin concentration QTL 1 | 1 | ****************************** |
| Blood pressure QTL 157 | 1 | ****************************** |
| Serum triglyceride level QTL 2 | 1 | ****************************** |
| CIA Autoantibody QTL 5 | 1 | ****************************** |
| Blood pressure QTL 240 | 1 | ****************************** |
| Aerobic running capacity QTL 2 | 1 | ****************************** |
| Blood pressure QTL 169 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 3 | 1 | ****************************** |
| Blood pressure QTL 35 | 1 | ****************************** |
| Kidney mass QTL 12 | 1 | ****************************** |
| Blood pressure QTL 180 | 1 | ****************************** |
| Blood pressure QTL 118 | 1 | ****************************** |
| Collagen induced arthritis QTL 18 | 1 | ****************************** |
| Limb length QTL 2 | 1 | ****************************** |
| Renal function QTL 19 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 35 | 1 | ****************************** |
| Blood pressure QTL 63 | 1 | ****************************** |
| Blood pressure QTL 251 | 1 | ****************************** |
| Blood pressure QTL 181 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 45 | 1 | ****************************** |
| X-ray hypersensitivity QTL 2 | 1 | ****************************** |
| Cardiac mass QTL 38 | 1 | ****************************** |
| Heart rate QTL 2 | 1 | ****************************** |
| X-ray hypersensitivity QTL 3 | 1 | ****************************** |
| Blood pressure QTL cluster 7 | 1 | ****************************** |
| Cardiac mass QTL 42 | 1 | ****************************** |
| Triglyceride level QTL 10 | 1 | ****************************** |
| Renal damage susceptibility QTL 3 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 25 | 1 | ****************************** |
| Serum triglyceride level QTL 14 | 1 | ****************************** |
| Blood pressure QTL 214 | 1 | ****************************** |
| Glomerulus QTL 3 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 8 | 1 | ****************************** |
| Ventral root avulsion QTL 4 | 1 | ****************************** |
| Blood pressure QTL 217 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 57 | 1 | ****************************** |
| Renal disease susceptibility QTL 5 | 1 | ****************************** |
| Body weight QTL 52 | 1 | ****************************** |
| Blood pressure QTL 206 | 1 | ****************************** |
| Urinary albumin excretion QTL 3 | 1 | ****************************** |
| Body weight QTL60 | 1 | ****************************** |
| Adjuvant induced arthritis QTL 5 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 7 | 1 | ****************************** |
| Blood pressure QTL 225 | 1 | ****************************** |
| Blood pressure QTL 153 | 1 | ****************************** |
| Cataract Ihara QTL 1 | 1 | ****************************** |
| Blood pressure QTL 26 | 1 | ****************************** |
| Cardiac mass QTL 53 | 1 | ****************************** |
| Renal function QTL 29 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 12 | 1 | ****************************** |
| Blood pressure QTL 104 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 1 | 1 | ****************************** |
| Serum cholesterol level QTL 49 | 1 | ****************************** |
| Body weight QTL 23 | 1 | ****************************** |
| Liver neoplastic nodule remodeling QTL 3 | 1 | ****************************** |
| Pristane induced arthritis QTL 13 | 1 | ****************************** |
| Blood pressure QTL 2 | 1 | ****************************** |
| Body weight QTL 57 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 1 | 1 | ****************************** |
| Blood pressure QTL 161 | 1 | ****************************** |
| Oil induced arthritis QTL 6 | 1 | ****************************** |
| Pristane induced arthritis QTL 2 | 1 | ****************************** |
| Bone structure and strength QTL 10 | 1 | ****************************** |
| Despair related QTL 6 | 1 | ****************************** |
| Stress response QTL 1 | 1 | ****************************** |
| Blood pressure QTL 134 | 1 | ****************************** |
| Collagen induced arthritis QTL 4 | 1 | ****************************** |
| Bone structure and strength QTL 14 | 1 | ****************************** |
| Body weight QTL 35 | 1 | ****************************** |
| Stress response QTL 5 | 1 | ****************************** |
| Blood pressure QTL 121 | 1 | ****************************** |
| Proteinuria QTL 1 | 1 | ****************************** |
| Kidney mass QTL 15 | 1 | ****************************** |
| Blood pressure QTL 242 | 1 | ****************************** |
| Aerobic running capacity QTL 1 | 1 | ****************************** |
| Body weight QTL 8 | 1 | ****************************** |
| Blood pressure QTL 37 | 1 | ****************************** |
| Blood pressure QTL 245 | 1 | ****************************** |
| Kidney mass QTL 7 | 1 | ****************************** |
| Blood pressure QTL 119 | 1 | ****************************** |
| Collagen induced arthritis QTL 2 | 1 | ****************************** |
| Kidney mass QTL 20 | 1 | ****************************** |
| Renal function QTL 22 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 36 | 1 | ****************************** |
| Body weight QTL 20 | 1 | ****************************** |
| Blood pressure QTL 260 | 1 | ****************************** |
| Blood pressure QTL 195 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 46 | 1 | ****************************** |
| Blood pressure QTL cluster 10 | 1 | ****************************** |
| Body weight QTL 47 | 1 | ****************************** |
| Blood pressure QTL 170 | 1 | ****************************** |
| Anxiety related response QTL 16 | 1 | ****************************** |
| Blood pressure QTL cluster 8 | 1 | ****************************** |
| Heart rate QTL 18 | 1 | ****************************** |
| Serum cholesterol QTL 19 | 1 | ****************************** |
| Renal damage susceptibility QTL 4 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 27 | 1 | ****************************** |
| Blood pressure QTL 250 | 1 | ****************************** |
| Renal function QTL 42 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 17 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 13 | 1 | ****************************** |
| Stress response QTL 11 | 1 | ****************************** |
| Blood pressure QTL 203 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 59 | 1 | ****************************** |
| Cardiac mass QTL 22 | 1 | ****************************** |
| Bone structure and strength QTL 5 | 1 | ****************************** |
| Blood pressure QTL 218 | 1 | ****************************** |
| Blood pressure QTL 148 | 1 | ****************************** |
| Body weight QTL61 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 6 | 1 | ****************************** |
| Schwannoma susceptibility QTL 7 | 1 | ****************************** |
| Body weight QTL 24 | 1 | ****************************** |
| Proteinuria QTL 3 | 1 | ****************************** |
| Left ventricular atrial natriuretic factor QTL 1 | 1 | ****************************** |
| Blood pressure QTL 27 | 1 | ****************************** |
| Stress response QTL 21 | 1 | ****************************** |
| Blood pressure QTL 200 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 4 | 1 | ****************************** |
| Blood pressure QTL 105 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 3 | 1 | ****************************** |
| Serum cholesterol level QTL 52 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 61 | 1 | ****************************** |
| Anxiety related response QTL 9 | 1 | ****************************** |
| Blood pressure QTL 75 | 1 | ****************************** |
| Blood pressure QTL 5 | 1 | ****************************** |
| Prostate cancer resistance QTL 1 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 10 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 60 | 1 | ****************************** |
| Body weight QTL 9 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 10 | 1 | ****************************** |
| Bone mineral density QTL 11 | 1 | ****************************** |
| Kidney mass QTL 21 | 1 | ****************************** |
| Liver neoplastic nodule remodeling QTL 4 | 1 | ****************************** |
| Blood pressure QTL 135 | 1 | ****************************** |
| Collagen induced arthritis QTL 5 | 1 | ****************************** |
| Bone mineral density QTL 10 | 1 | ****************************** |
| Blood pressure QTL 243 | 1 | ****************************** |
| Activity QTL 2 | 1 | ****************************** |
| Serum triglyceride level QTL 4 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 7 | 1 | ****************************** |
| Kidney mass QTL 19 | 1 | ****************************** |
| Glomerulus QTL 7 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 9 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL x | 1 | ****************************** |
| Limb length QTL 1 | 1 | ****************************** |
| Heart rate QTL 1 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 1 | 1 | ****************************** |
| Blood pressure QTL 12 | 1 | ****************************** |
| Despair related QTL 9 | 1 | ****************************** |
| Blood pressure QTL 186 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 37 | 1 | ****************************** |
| Body weight QTL 21 | 1 | ****************************** |
| Body weight QTL 50 | 1 | ****************************** |
| Blood pressure QTL 171 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 47 | 1 | ****************************** |
| Blood pressure QTL cluster 11 | 1 | ****************************** |
| Blood pressure QTL 252 | 1 | ****************************** |
| Blood pressure QTL 177 | 1 | ****************************** |
| Anxiety related response QTL 17 | 1 | ****************************** |
| Blood pressure QTL cluster 9 | 1 | ****************************** |
| Blood pressure QTL 273 | 1 | ****************************** |
| Triglyceride level QTL 8 | 1 | ****************************** |
| Kidney mass QTL 1 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 28 | 1 | ****************************** |
| Body weight QTL 40 | 1 | ****************************** |
| Serum cholesterol level QTL 27 | 1 | ****************************** |
| Blood pressure QTL 150 | 1 | ****************************** |
| Carrageenan-induced inflammation QTL 2 | 1 | ****************************** |
| Body weight QTL 54 | 1 | ****************************** |
| Kidney mass QTL 9 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 58 | 1 | ****************************** |
| Cardiac mass QTL 23 | 1 | ****************************** |
| Blood pressure QTL 256 | 1 | ****************************** |
| Renal function QTL 40 | 1 | ****************************** |
| Urinary albumin excretion QTL 4 | 1 | ****************************** |
| Serum triglyceride level QTL 8 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 7 | 1 | ****************************** |
| Collagen induced arthritis QTL 28 | 1 | ****************************** |
| Renal function QTL 28 | 1 | ****************************** |
| Glomerulus QTL 6 | 1 | ****************************** |
| Cataract Ihara QTL 2 | 1 | ****************************** |
| Blood pressure QTL 28 | 1 | ****************************** |
| Toxoplasma gondii resistance QTL 1 | 1 | ****************************** |
| Blood pressure QTL 202 | 1 | ****************************** |
| Alcohol consumption QTL 9 | 1 | ****************************** |
| Serum aldosterone level QTL 1 | 1 | ****************************** |
| Estrogen-dependent pituitary mass QTL 1 | 1 | ****************************** |
| Serum cholesterol level QTL 50 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 18b | 1 | ****************************** |
| Anxiety related response QTL 3 | 1 | ****************************** |
| Pristane induced arthritis QTL 14 | 1 | ****************************** |
| Blood pressure QTL 6 | 1 | ****************************** |
| Body weight QTL 56 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 13 | 1 | ****************************** |
| Pristane induced arthritis QTL 24 | 1 | ****************************** |
| Blood pressure QTL 81 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 11 | 1 | ****************************** |
| Vascular neointimal growth QTL 2 | 1 | ****************************** |
| Brain ventricular dilatation QTL 6 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 6 | 1 | ****************************** |
| Blood pressure QTL 136 | 1 | ****************************** |
| Collagen induced arthritis QTL 6 | 1 | ****************************** |
| Bone mineral density QTL 16 | 1 | ****************************** |
| Body weight QTL 36 | 1 | ****************************** |
| Blood pressure QTL 163 | 1 | ****************************** |
| Blood pressure QTL 122 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 8 | 1 | ****************************** |
| Renal function QTL 47 | 1 | ****************************** |
| Glomerulus QTL 8 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 10 | 1 | ****************************** |
| Oil induced arthritis QTL 2 | 1 | ****************************** |
| Serum cholesterol level QTL 30 | 1 | ****************************** |
| White blood cell count QTL 1 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 2 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 12 | 1 | ****************************** |
| Serum phospholipid level QTL 7 | 1 | ****************************** |
| Heart rate QTL 9 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 38 | 1 | ****************************** |
| Blood pressure QTL 64 | 1 | ****************************** |
| Blood pressure QTL 264 | 1 | ****************************** |
| Blood pressure QTL 189 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 48 | 1 | ****************************** |
| Blood pressure QTL cluster 12 | 1 | ****************************** |
| Cardiac mass QTL 39 | 1 | ****************************** |
| Renal function QTL 6 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 4 | 1 | ****************************** |
| Compensatory renal growth QTL 1 | 1 | ****************************** |
| Blood pressure QTL 274 | 1 | ****************************** |
| Serum cholesterol QTL 20 | 1 | ****************************** |
| Cardiac mass QTL 19 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 29 | 1 | ****************************** |
| Glucose level QTL 4 | 1 | ****************************** |
| Blood pressure QTL 216 | 1 | ****************************** |
| Proteinuria QTL 2 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 14 | 1 | ****************************** |
| Stress response QTL 9 | 1 | ****************************** |
| Heart rate QTL 16 | 1 | ****************************** |
| Urinary albumin excretion QTL 14 | 1 | ****************************** |
| Cardiac mass QTL 25 | 1 | ****************************** |
| Blood pressure QTL 248 | 1 | ****************************** |
| White blood cell count QTL 2 | 1 | ****************************** |
| Cardiac mass QTL 16 | 1 | ****************************** |
| Serum triglyceride level QTL 9 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 8 | 1 | ****************************** |
| Schwannoma susceptibility QTL 1 | 1 | ****************************** |
| Renal function QTL 38 | 1 | ****************************** |
| Blood pressure QTL 151 | 1 | ****************************** |
| Serum phospholipid level QTL 3 | 1 | ****************************** |
| Renal disease susceptibility QTL 1 | 1 | ****************************** |
| Kidney mass QTL 29 | 1 | ****************************** |
| Renal function QTL 30 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 9 | 1 | ****************************** |
| Serum aldosterone level QTL 2 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 4 | 1 | ****************************** |
| Serum cholesterol level QTL 51 | 1 | ****************************** |
| Body weight QTL 44 | 1 | ****************************** |
| Alcohol consumption QTL 15 | 1 | ****************************** |
| Blood pressure QTL 76 | 1 | ****************************** |
| Blood pressure QTL 7 | 1 | ****************************** |
| Spike wave discharge measurement QTL 4 | 1 | ****************************** |
| Estrogen-induced mammary cancer QTL 2 | 1 | ****************************** |
| Blood pressure QTL 160 | 1 | ****************************** |
| Blood pressure QTL 82 | 1 | ****************************** |
| Pristane induced arthritis QTL 4 | 1 | ****************************** |
| Bone structure and strength QTL 12 | 1 | ****************************** |
| Body weight QTL 31 | 1 | ****************************** |
| Serum cholesterol level QTL 16 | 1 | ****************************** |
| Blood pressure QTL 137 | 1 | ****************************** |
| Collagen induced arthritis QTL 7 | 1 | ****************************** |
| Bone mineral density QTL 13 | 1 | ****************************** |
| Renal function QTL 48 | 1 | ****************************** |
| Collagen induced arthritis QTL 25 | 1 | ****************************** |
| Serum triglyceride level QTL 5 | 1 | ****************************** |
| Blood pressure QTL 10 | 1 | ****************************** |
| Kidney mass QTL 16 | 1 | ****************************** |
| Renal function QTL 18 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 11 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 3 | 1 | ****************************** |
| Insulin level QTL 1 | 1 | ****************************** |
| Blood pressure QTL 194 | 1 | ****************************** |
| Serum cholesterol level QTL 4 | 1 | ****************************** |
| Blood pressure QTL 16 | 1 | ****************************** |
| Blood pressure QTL 241 | 1 | ****************************** |
| Heart rate QTL 6 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 39 | 1 | ****************************** |
| Blood pressure QTL 65 | 1 | ****************************** |
| Blood pressure QTL 261 | 1 | ****************************** |
| Blood pressure QTL 174 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 49 | 1 | ****************************** |
| Blood pressure QTL cluster 13 | 1 | ****************************** |
| Heart rate QTL 17 | 1 | ****************************** |
| Blood pressure QTL 184 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 50 | 1 | ****************************** |
| Alcohol consumption QTL 18 | 1 | ****************************** |
| Blood pressure QTL 276 | 1 | ****************************** |
| Triglyceride level QTL 9 | 1 | ****************************** |
| Urinary albumin excretion QTL 8 | 1 | ****************************** |
| Cardiac mass QTL 14 | 1 | ****************************** |
| Blood pressure QTL 249 | 1 | ****************************** |
| Serum renin concentration QTL 4 | 1 | ****************************** |
| Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 15 | 1 | ****************************** |
| Blood pressure QTL 268 | 1 | ****************************** |
| Blood pressure QTL 215 | 1 | ****************************** |
| Urinary albumin excretion QTL 15 | 1 | ****************************** |
| Pancreas inflammation QTL 1 | 1 | ****************************** |
| Body weight QTL 53 | 1 | ****************************** |
| Blood pressure QTL 205 | 1 | ****************************** |
| Blood pressure QTL 149 | 1 | ****************************** |
| Activity QTL 1 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 9 | 1 | ****************************** |
| Pristane induced arthritis QTL 26 | 1 | ****************************** |
| Blood pressure QTL 238 | 1 | ****************************** |
| Urinary albumin excretion QTL 22 | 1 | ****************************** |
| Blood pressure QTL 95 | 1 | ****************************** |
| Renal disease susceptibility QTL 2 | 1 | ****************************** |
| Kidney lesion grade QTL 1 | 1 | ****************************** |
| Thyroid stimulating hormone level QTL 2 | 1 | ****************************** |
| Alcohol consumption QTL 10 | 1 | ****************************** |
| Pristane induced arthritis QTL 7 | 1 | ****************************** |
| Estrogen-dependent pituitary mass QTL 2 | 1 | ****************************** |
| Intracellular calcium level QTL 1 | 1 | ****************************** |
| Body weight QTL 41 | 1 | ****************************** |
| Anxiety related response QTL 15 | 1 | ****************************** |
| T-lymphoma susceptibility QTL 1 | 1 | ****************************** |
| Blood pressure QTL 8 | 1 | ****************************** |
| Prostate cancer susceptibility QTL 1 | 1 | ****************************** |
| Insulin/glucose ratio QTL 2 | 1 | ****************************** |
| Pristane induced arthritis QTL 23 | 1 | ****************************** |
| Blood pressure QTL 83 | 1 | ****************************** |
| Pristane induced arthritis QTL 5 | 1 | ****************************** |
| Bone structure and strength QTL 13 | 1 | ****************************** |
| Despair related QTL 11 | 1 | ****************************** |
| Blood pressure QTL 159 | 1 | ****************************** |
| Acute phase response QTL 1 | 1 | ****************************** |
| Thermal response to stress QTL 1 | 1 | ****************************** |
| Bone mineral density QTL 12 | 1 | ****************************** |
| Blood pressure QTL 246 | 1 | ****************************** |
| Stress response QTL 4 | 1 | ****************************** |
| Blood pressure QTL 123 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 10 | 1 | ****************************** |
| Renal function QTL 46 | 1 | ****************************** |
| Renal function QTL 8 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 12 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 2 | 1 | ****************************** |
| Serum phospholipid level QTL 5 | 1 | ****************************** |
| Cardiac mass QTL 4 | 1 | ****************************** |
| Serum cholesterol level QTL 5 | 1 | ****************************** |
| Adjuvant induced arthritis QTL 1 | 1 | ****************************** |
| Brain ventricular dilatation QTL 4 | 1 | ****************************** |
| Serum renin concentration QTL 3 | 1 | ****************************** |
| Infertility severity QTL 1 | 1 | ****************************** |
| Body weight QTL 22 | 1 | ****************************** |
| Blood pressure QTL 259 | 1 | ****************************** |
| Blood pressure QTL 179 | 1 | ****************************** |
| Hypercalciuria QTL 1 | 1 | ****************************** |
| Blood pressure QTL cluster 14 | 1 | ****************************** |
| Blood pressure QTL 253 | 1 | ****************************** |
| Blood pressure QTL 172 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 5 | 1 | ****************************** |
| Gastric cancer resistance QTL 1 | 1 | ****************************** |
| Heart rate QTL 21 | 1 | ****************************** |
| Serum cholesterol QTL 21 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 53 | 1 | ****************************** |
| Cardiac mass QTL 28 | 1 | ****************************** |
| Aortic elastin QTL 1 | 1 | ****************************** |
| Blood pressure QTL 233 | 1 | ****************************** |
| Polydactyly-luxate syndrome (PLS) morphotypes QTL 2 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 16 | 1 | ****************************** |
| Serum cholesterol level QTL 46 | 1 | ****************************** |
| Heart rate QTL 11 | 1 | ****************************** |
| Urinary albumin excretion QTL 16 | 1 | ****************************** |
| Glucose level QTL 13 | 1 | ****************************** |
| Bone structure and strength QTL 7 | 1 | ****************************** |
| Heart rate QTL 15 | 1 | ****************************** |
| Urinary albumin excretion QTL 5 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 2 | 1 | ****************************** |
| Experimental allergic uveoritinitis QTL 1 | 1 | ****************************** |
| Pristane induced arthritis QTL 25 | 1 | ****************************** |
| Serum cholesterol level QTL 28 | 1 | ****************************** |
| Urinary albumin excretion QTL 23 | 1 | ****************************** |
| Blood pressure QTL 96 | 1 | ****************************** |
| Blood pressure QTL 30 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 11 | 1 | ****************************** |
| Blood pressure QTL 213 | 1 | ****************************** |
| Alcohol consumption QTL 12 | 1 | ****************************** |
| Serum cholesterol level QTL 6 | 1 | ****************************** |
| Blood pressure QTL 42 | 1 | ****************************** |
| Prostate cancer susceptibility QTL 2 | 1 | ****************************** |
| Serum leptin concentration QTL 3 | 1 | ****************************** |
| Pristane induced arthritis QTL 9 | 1 | ****************************** |
| Serum cholesterol level QTL 11 | 1 | ****************************** |
| Blood pressure QTL 9 | 1 | ****************************** |
| Cardiac mass QTL 43 | 1 | ****************************** |
| Glucose level QTL12 | 1 | ****************************** |
| Pristane induced arthritis QTL 22 | 1 | ****************************** |
| Blood pressure QTL 84 | 1 | ****************************** |
| Collagen induced arthritis QTL 11 | 1 | ****************************** |
| Trichinella spiralis expulsion QTL 1 | 1 | ****************************** |
| Cardiac mass QTL 36 | 1 | ****************************** |
| Serum cholesterol level QTL 15 | 1 | ****************************** |
| Hepatic copper content QTL 2 | 1 | ****************************** |
| Sensitivity to stroke QTL 1 | 1 | ****************************** |
| Bone structure and strength QTL 17 | 1 | ****************************** |
| Adrenal mass QTL 1 | 1 | ****************************** |
| Blood pressure QTL 158 | 1 | ****************************** |
| Serum triglyceride level QTL 6 | 1 | ****************************** |
| Blood pressure QTL 13 | 1 | ****************************** |
| Cardiac mass QTL35 | 1 | ****************************** |
| Renal function QTL 13 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 13 | 1 | ****************************** |
| Blood pressure QTL 40 | 1 | ****************************** |
| Serum cholesterol level QTL 32 | 1 | ****************************** |
| Renal function QTL 26 | 1 | ****************************** |
| Alcohol consumption QTL 4 | 1 | ****************************** |
| Adjuvant induced arthritis QTL 2 | 1 | ****************************** |
| Despair related QTL 13 | 1 | ****************************** |
| Blood pressure QTL 178 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 42 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 12 | 1 | ****************************** |
| Blood pressure QTL 265 | 1 | ****************************** |
| Renal function QTL 21 | 1 | ****************************** |
| Body weight QTL 12 | 1 | ****************************** |
| Blood pressure QTL cluster 15 | 1 | ****************************** |
| Cardiac mass QTL 40 | 1 | ****************************** |
| Renal function QTL 11 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 51 | 1 | ****************************** |
| Alcohol consumption QTL 19 | 1 | ****************************** |
| Heart rate QTL 20 | 1 | ****************************** |
| Body weight QTL 16 | 1 | ****************************** |
| Kidney mass QTL 2 | 1 | ****************************** |
| Blood pressure QTL 54 | 1 | ****************************** |
| Stress response QTL 12 | 1 | ****************************** |
| Blood pressure QTL 204 | 1 | ****************************** |
| Pancreatic morphology QTL 1 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 17 | 1 | ****************************** |
| Serum cholesterol level QTL 48 | 1 | ****************************** |
| Blood pressure QTL 220 | 1 | ****************************** |
| Urinary albumin excretion QTL 17 | 1 | ****************************** |
| Glucose level QTL 14 | 1 | ****************************** |
| Serum cholesterol level QTL 44 | 1 | ****************************** |
| Blood pressure QTL 236 | 1 | ****************************** |
| Cardiac mass QTL 17 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 3 | 1 | ****************************** |
| Experimental allergic uveoritinitis QTL 2 | 1 | ****************************** |
| Estrogen induced uterine response QTL 1 | 1 | ****************************** |
| Renal function QTL 36 | 1 | ****************************** |
| Urinary albumin excretion QTL 20 | 1 | ****************************** |
| Blood pressure QTL 97 | 1 | ****************************** |
| Blood pressure QTL 31 | 1 | ****************************** |
| Stress response QTL 22 | 1 | ****************************** |
| Blood pressure QTL 224 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 10 | 1 | ****************************** |
| Serum cholesterol level QTL 7 | 1 | ****************************** |
| Estrogen-dependent pituitary mass QTL 3 | 1 | ****************************** |
| Cardiac mass QTL 47 | 1 | ****************************** |
| Alcohol consumption QTL 16 | 1 | ****************************** |
| T-lymphoma susceptibility QTL 2 | 1 | ****************************** |
| Body weight QTL 17 | 1 | ****************************** |
| Body weight QTL 59 | 1 | ****************************** |
| Glucose level QTL 11 | 1 | ****************************** |
| Stress response QTL 3 | 1 | ****************************** |
| Blood pressure QTL 85 | 1 | ****************************** |
| Pristane induced arthritis QTL 6 | 1 | ****************************** |
| Bone structure and strength QTL 19 | 1 | ****************************** |
| Renal function QTL 50 | 1 | ****************************** |
| Blood pressure QTL 167 | 1 | ****************************** |
| Acute phase response QTL 2 | 1 | ****************************** |
| Thermal response to stress QTL 2 | 1 | ****************************** |
| Cardiac mass QTL 33 | 1 | ****************************** |
| Thymus enlargement QTL 4 | 1 | ****************************** |
| Blood pressure QTL 124 | 1 | ****************************** |
| Blood pressure QTL 14 | 1 | ****************************** |
| Despair related QTL 7 | 1 | ****************************** |
| Serum triglyceride level QTL 7 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 14 | 1 | ****************************** |
| Blood pressure QTL 41 | 1 | ****************************** |
| Brain ventricular dilatation QTL 3 | 1 | ****************************** |
| Blood pressure QTL 175 | 1 | ****************************** |
| Alcohol consumption QTL 5 | 1 | ****************************** |
| Blood pressure QTL 59 | 1 | ****************************** |
| Serum phospholipid level QTL 8 | 1 | ****************************** |
| Blood pressure QTL 191 | 1 | ****************************** |
| Mammary tumor resistance QTL 1 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 13 | 1 | ****************************** |
| Kidney mass QTL 26 | 1 | ****************************** |
| Blood pressure QTL 173 | 1 | ****************************** |
| Hypercalciuria QTL 2 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 26 | 1 | ****************************** |
| Body weight QTL 49 | 1 | ****************************** |
| Body weight QTL 15 | 1 | ****************************** |
| Collagen induced arthritis QTL 24 | 1 | ****************************** |
| Gastric cancer resistance QTL 2 | 1 | ****************************** |
| Heart rate QTL 19 | 1 | ****************************** |
| Triglyceride level QTL 7 | 1 | ****************************** |
| Cardiac mass QTL 20 | 1 | ****************************** |
| Blood pressure QTL 55 | 1 | ****************************** |
| Ventral root avulsion QTL 5 | 1 | ****************************** |
| Renal function QTL 44 | 1 | ****************************** |
| Polydactyly-luxate syndrome (PLS) morphotypes QTL 3 | 1 | ****************************** |
| Thymus enlargement QTL 1 | 1 | ****************************** |
| Bone structure and strength QTL 1 | 1 | ****************************** |
| Blood pressure QTL 199 | 1 | ****************************** |
| Urinary albumin excretion QTL 18 | 1 | ****************************** |
| Glucose level QTL 15 | 1 | ****************************** |
| Serum cholesterol level QTL 47 | 1 | ****************************** |
| Heart rate QTL 12 | 1 | ****************************** |
| Renal function QTL 51 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 4 | 1 | ****************************** |
| Experimental allergic uveoritinitis QTL 3 | 1 | ****************************** |
| Schwannoma susceptibility QTL 6 | 1 | ****************************** |
| Blood pressure QTL 221 | 1 | ****************************** |
| Glomerulus QTL 5 | 1 | ****************************** |
| Blood pressure QTL 98 | 1 | ****************************** |
| Blood pressure QTL 33 | 1 | ****************************** |
| Urinary albumin excretion QTL 31 | 1 | ****************************** |
| Blood pressure QTL 211 | 1 | ****************************** |
| Alcohol consumption QTL 13 | 1 | ****************************** |
| Serum cholesterol level QTL8 | 1 | ****************************** |
| Blood pressure QTL 43 | 1 | ****************************** |
| Prostate cancer resistance QTL 2 | 1 | ****************************** |
| Body weight QTL62 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 7 | 1 | ****************************** |
| T-lymphoma susceptibility QTL 3 | 1 | ****************************** |
| Blood pressure QTL 50 | 1 | ****************************** |
| Testicular tumor resistance QTL 1 | 1 | ****************************** |
| Serum triglyceride level QTL 19 | 1 | ****************************** |
| Liver neoplastic nodule remodeling QTL 5 | 1 | ****************************** |
| Blood pressure QTL 86 | 1 | ****************************** |
| Collagen induced arthritis QTL 13 | 1 | ****************************** |
| Bone structure and strength QTL 20 | 1 | ****************************** |
| Serum triglyceride level QTL 12 | 1 | ****************************** |
| Blood pressure QTL 168 | 1 | ****************************** |
| Hepatic copper content QTL 3 | 1 | ****************************** |
| Sensitivity to stroke QTL 2 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 62 | 1 | ****************************** |
| Blood pressure QTL 165 | 1 | ****************************** |
| Blood pressure QTL 106 | 1 | ****************************** |
| Blood pressure QTL 15 | 1 | ****************************** |
| Brain ventricular dilatation QTL 1 | 1 | ****************************** |
| Renal function QTL 12 | 1 | ****************************** |
| Cardiac mass QTL 8 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 3 | 1 | ****************************** |
| Food consumption QTL 2 | 1 | ****************************** |
| Serum renin concentration QTL 1 | 1 | ****************************** |
| Alcohol consumption QTL 6 | 1 | ****************************** |
| Insulin level QTL 2 | 1 | ****************************** |
| Serum phospholipid level QTL 6 | 1 | ****************************** |
| Renal function QTL 14 | 1 | ****************************** |
| Blood pressure QTL 140 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 14 | 1 | ****************************** |
| Blood pressure QTL 263 | 1 | ****************************** |
| Kidney mass QTL 4 | 1 | ****************************** |
| Body weight QTL 13 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 18 | 1 | ****************************** |
| Kidney mass QTL 25 | 1 | ****************************** |
| Cardiac mass QTL 5 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 6 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 20 | 1 | ****************************** |
| Prepulse inhibition QTL 2 | 1 | ****************************** |
| Renal function QTL 43 | 1 | ****************************** |
| Urinary albumin excretion QTL 9 | 1 | ****************************** |
| Blood pressure QTL 56 | 1 | ****************************** |
| Stress response QTL 8 | 1 | ****************************** |
| Blood pressure QTL 227 | 1 | ****************************** |
| Polydactyly-luxate syndrome (PLS) morphotypes QTL 4 | 1 | ****************************** |
| Thymus enlargement QTL 2 | 1 | ****************************** |
| Bone structure and strength QTL 6 | 1 | ****************************** |
| Body weight QTL 27 | 1 | ****************************** |
| Urinary albumin excretion QTL 19 | 1 | ****************************** |
| Blood pressure QTL 196 | 1 | ****************************** |
| Bone structure and strength QTL 8 | 1 | ****************************** |
| Kidney mass QTL 10 | 1 | ****************************** |
| Urinary albumin excretion QTL 6 | 1 | ****************************** |
| Cardiac mass QTL 24 | 1 | ****************************** |
| Glucose level QTL 16 | 1 | ****************************** |
| Estrogen induced uterine response QTL 2 | 1 | ****************************** |
| Blood pressure QTL 222 | 1 | ****************************** |
| Urinary albumin excretion QTL 26 | 1 | ****************************** |
| Blood pressure QTL 100 | 1 | ****************************** |
| Blood pressure QTL 34 | 1 | ****************************** |
| Stress response QTL 23 | 1 | ****************************** |
| Serum cholesterol level QTL 25 | 1 | ****************************** |
| Alcohol consumption QTL 11 | 1 | ****************************** |
| Body weight QTL 10 | 1 | ****************************** |
| Blood pressure QTL 44 | 1 | ****************************** |
| Cardiac mass QTL 44 | 1 | ****************************** |
| Body weight QTL 43 | 1 | ****************************** |
| Anxiety related response QTL 4 | 1 | ****************************** |
| Immunoglobin response QTL2 | 1 | ****************************** |
| Tongue tumor resistance QTL 1 | 1 | ****************************** |
| Bone mineral density QTL 18 | 1 | ****************************** |
| Insulin/glucose ratio QTL 1 | 1 | ****************************** |
| Liver neoplastic nodule remodeling QTL 6 | 1 | ****************************** |
| Blood pressure QTL 87 | 1 | ****************************** |
| Collagen induced arthritis QTL 14 | 1 | ****************************** |
| Bone structure and strength QTL 15 | 1 | ****************************** |
| Despair related QTL 10 | 1 | ****************************** |
| Serum cholesterol level QTL 18 | 1 | ****************************** |
| Acute phase response QTL 3 | 1 | ****************************** |
| Sensitivity to stroke QTL 3 | 1 | ****************************** |
| Body weight QTL 34 | 1 | ****************************** |
| Blood pressure QTL 156 | 1 | ****************************** |
| Blood pressure QTL 125 | 1 | ****************************** |
| Blood pressure QTL 17 | 1 | ****************************** |
| Despair related QTL 14 | 1 | ****************************** |
| Blood pressure QTL 183 | 1 | ****************************** |
| Cardiac mass QTL 9 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 6 | 1 | ****************************** |
| Serum phospholipid level QTL 4 | 1 | ****************************** |
| Renal function QTL 16 | 1 | ****************************** |
| Alcohol consumption QTL 7 | 1 | ****************************** |
| Gastric cancer susceptibility QTL1 | 1 | ****************************** |
| Saline consumption QTL 1 | 1 | ****************************** |
| Renal function QTL 23 | 1 | ****************************** |
| Blood pressure QTL 141 | 1 | ****************************** |
| Carrageenan-induced inflammation QTL 1 | 1 | ****************************** |
| Kidney mass QTL 24 | 1 | ****************************** |
| Heart rate QTL 3 | 1 | ****************************** |
| Hypercalciuria QTL 3 | 1 | ****************************** |
| Blood pressure QTL cluster 1 | 1 | ****************************** |
| Kidney mass QTL 27 | 1 | ****************************** |
| Heart rate QTL 10 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 7 | 1 | ****************************** |
| Gastric cancer resistance QTL 3 | 1 | ****************************** |
| Blood pressure QTL 271 | 1 | ****************************** |
| Blood pressure QTL 210 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 54 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 2 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 20 | 1 | ****************************** |
| Urinary albumin excretion QTL 29 | 1 | ****************************** |
| Renal damage susceptibility QTL 1 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 21 | 1 | ****************************** |
| Bone structure and strength QTL 3 | 1 | ****************************** |
| Blood pressure QTL 231 | 1 | ****************************** |
| Blood pressure QTL 144 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 40 | 1 | ****************************** |
| Blood pressure QTL 278 | 1 | ****************************** |
| Renal function QTL 39 | 1 | ****************************** |
| Cardiac mass QTL 18 | 1 | ****************************** |
| Serum cholesterol level QTL 22 | 1 | ****************************** |
| Glucose level QTL 17 | 1 | ****************************** |
| Schwannoma susceptibility QTL 5 | 1 | ****************************** |
| Renal function QTL 27 | 1 | ****************************** |
| Oil induced arthritis QTL 7 | 1 | ****************************** |
| Serum triglyceride level QTL 1 | 1 | ****************************** |
| Pristane induced arthritis QTL 10 | 1 | ****************************** |
| Stress response QTL 14 | 1 | ****************************** |
| Renal function QTL 33 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 11 | 1 | ****************************** |
| Glucose level QTL 31 | 1 | ****************************** |
| Estrogen-dependent pituitary mass QTL 5 | 1 | ****************************** |
| Cardiac mass QTL 45 | 1 | ****************************** |
| Serum leptin concentration QTL 4 | 1 | ****************************** |
| Anxiety related response QTL 10 | 1 | ****************************** |
| Cardiac mass QTL 50 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 1 | 1 | ****************************** |
| Bone mineral density QTL 17 | 1 | ****************************** |
| Cardiac mass QTL 37 | 1 | ****************************** |
| Anxiety related response QTL 12 | 1 | ****************************** |
| Blood pressure QTL 88 | 1 | ****************************** |
| Collagen induced arthritis QTL 15 | 1 | ****************************** |
| Bone structure and strength QTL 18 | 1 | ****************************** |
| Despair related QTL 4 | 1 | ****************************** |
| Hepatic copper content QTL 4 | 1 | ****************************** |
| Compensatory renal growth QTL 2 | 1 | ****************************** |
| Despair related QTL 2 | 1 | ****************************** |
| Insulin dependent diabetes mellitus QTL 18 | 1 | ****************************** |
| Blood pressure QTL 107 | 1 | ****************************** |
| Blood pressure QTL 18 | 1 | ****************************** |
| Serum triglyceride level QTL 13 | 1 | ****************************** |
| Blood pressure QTL 176 | 1 | ****************************** |
| Cardiac mass QTL 10 | 1 | ****************************** |
| Serum cholesterol level QTL 23 | 1 | ****************************** |
| Spike wave discharge measurement QTL 1 | 1 | ****************************** |
| Renal function QTL 25 | 1 | ****************************** |
| Alcohol consumption QTL 8 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 30 | 1 | ****************************** |
| Body weight QTL 33 | 1 | ****************************** |
| Renal function QTL 7 | 1 | ****************************** |
| Saccharin preference QTL 6 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 15 | 1 | ****************************** |
| Blood pressure QTL 254 | 1 | ****************************** |
| Renal function QTL 10 | 1 | ****************************** |
| Hypercalciuria QTL 4 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 5 | 1 | ****************************** |
| Kidney mass QTL 28 | 1 | ****************************** |
| Cardiac mass QTL 2 | 1 | ****************************** |
| Insulin level 4 | 1 | ****************************** |
| Alcohol consumption QTL 20 | 1 | ****************************** |
| Prepulse inhibition QTL 1 | 1 | ****************************** |
| Thyroid stimulating hormone level QTL 1 | 1 | ****************************** |
| Kidney mass QTL 3 | 1 | ****************************** |
| Blood pressure QTL 57 | 1 | ****************************** |
| Ventral root avulsion QTL 2 | 1 | ****************************** |
| Blood pressure QTL 209 | 1 | ****************************** |
| Urinary albumin excretion QTL 10 | 1 | ****************************** |
| Blood pressure QTL 77 | 1 | ****************************** |
| Blood pressure QTL 257 | 1 | ****************************** |
| Blood pressure QTL 230 | 1 | ****************************** |
| Blood pressure QTL 145 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 41 | 1 | ****************************** |
| Bone mineral density QTL 4 | 1 | ****************************** |
| Blood pressure QTL 234 | 1 | ****************************** |
| Urinary albumin excretion QTL 7 | 1 | ****************************** |
| Immunoglobin response QTL1 | 1 | ****************************** |
| Blood pressure QTL 20 | 1 | ****************************** |
| Collagen induced arthritis QTL 29 | 1 | ****************************** |
| Kidney mass QTL 11 | 1 | ****************************** |
| Mammary tumor resistance QTL 3 | 1 | ****************************** |
| Blood pressure QTL 99 | 1 | ****************************** |
| Blood pressure QTL 36 | 1 | ****************************** |
| Stress response QTL 18 | 1 | ****************************** |
| Serum renin concentration QTL 5 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 3 | 1 | ****************************** |
| Serum cholesterol level QTL 9 | 1 | ****************************** |
| Blood pressure QTL 45 | 1 | ****************************** |
| Body weight QTL 55 | 1 | ****************************** |
| Body weight QTL 42 | 1 | ****************************** |
| Pristane induced arthritis QTL 8 | 1 | ****************************** |
| Immunoglobin response QTL3 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 2 | 1 | ****************************** |
| Bone structure and strength QTL 11 | 1 | ****************************** |
| Body weight QTL 37 | 1 | ****************************** |
| Stress response QTL 2 | 1 | ****************************** |
| Blood pressure QTL 89 | 1 | ****************************** |
| Serum cholesterol level QTL 2 | 1 | ****************************** |
| Bone mineral QTL density 9 | 1 | ****************************** |
| Body weight QTL 32 | 1 | ****************************** |
| Collagen induced arthritis QTL 26 | 1 | ****************************** |
| Blood pressure QTL 90 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 1 | 1 | ****************************** |
| Food consumption QTL 1 | 1 | ****************************** |
| Serum cholesterol level QTL 14 | 1 | ****************************** |
| Blood pressure QTL 126 | 1 | ****************************** |
| Blood pressure QTL 19 | 1 | ****************************** |
| Serum cholesterol level QTL 31 | 1 | ****************************** |
| Serum renin concentration QTL 2 | 1 | ****************************** |
| Cardiac mass QTL 11 | 1 | ****************************** |
| Pristane induced arthritis QTL 3 | 1 | ****************************** |
| Kidney mass QTL 18 | 1 | ****************************** |
| Renal function QTL 20 | 1 | ****************************** |
| Saccharin preference QTL 1 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 32 | 1 | ****************************** |
| Renal function QTL 49 | 1 | ****************************** |
| Renal function QTL 17 | 1 | ****************************** |
| Blood pressure QTL 142 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 19 | 1 | ****************************** |
| Blood pressure QTL 262 | 1 | ****************************** |
| Blood pressure QTL 188 | 1 | ****************************** |
| Pristane induced arthritis QTL 15 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 6 | 1 | ****************************** |
| Body weight QTL 51 | 1 | ****************************** |
| Heart rate QTL 4 | 1 | ****************************** |
| Blood pressure QTL 138 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 31 | 1 | ****************************** |
| Blood pressure QTL 272 | 1 | ****************************** |
| Body weight QTL 25 | 1 | ****************************** |
| Cardiac mass QTL 21 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 3 | 1 | ****************************** |
| Blood pressure QTL 269 | 1 | ****************************** |
| Heart rate QTL 14 | 1 | ****************************** |
| Urinary albumin excretion QTL 11 | 1 | ****************************** |
| Blood pressure QTL 78 | 1 | ****************************** |
| Serum cholesterol level QTL 45 | 1 | ****************************** |
| Blood pressure QTL 219 | 1 | ****************************** |
| Urinary albumin excretion QTL 1 | 1 | ****************************** |
| Body weight QTL1 | 1 | ****************************** |
| Bone mineral density QTL 5 | 1 | ****************************** |
| Renal function QTL 35 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 52 | 1 | ****************************** |
| Blood pressure QTL 132 | 1 | ****************************** |
| Blood pressure QTL 21 | 1 | ****************************** |
| Stress response QTL 16 | 1 | ****************************** |
| Renal function QTL 41 | 1 | ****************************** |
| Blood pressure QTL 152 | 1 | ****************************** |
| Blood pressure QTL 101 | 1 | ****************************** |
| Blood pressure QTL 38 | 1 | ****************************** |
| Stress response QTL 15 | 1 | ****************************** |
| Renal function QTL 32 | 1 | ****************************** |
| Anxiety related response QTL 11 | 1 | ****************************** |
| Body weight QTL 11 | 1 | ****************************** |
| Blood pressure QTL 46 | 1 | ****************************** |
| Spike wave discharge measurement QTL 5 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 6 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 13 | 1 | ****************************** |
| Liver neoplastic nodule remodeling QTL 1 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 4 | 1 | ****************************** |
| Bone mineral density QTL 8 | 1 | ****************************** |
| Aortic cell protein QTL 1 | 1 | ****************************** |
| Anxiety related response QTL 8 | 1 | ****************************** |
| Body weight QTL 7 | 1 | ****************************** |
| Serum cholesterol level QTL 3 | 1 | ****************************** |
| Bone structure and strength QTL 16 | 1 | ****************************** |
| Kidney mass QTL 13 | 1 | ****************************** |
| Cardiac mass QTL 13 | 1 | ****************************** |
| Blood pressure QTL 91 | 1 | ****************************** |
| CIA Autoantibody QTL 1 | 1 | ****************************** |
| Kidney mass QTL 14 | 1 | ****************************** |
| Blood pressure QTL 155 | 1 | ****************************** |
| Blood pressure QTL 108 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 1 | 1 | ****************************** |
| Cardiac mass QTL 34 | 1 | ****************************** |
| Heart rate QTL 7 | 1 | ****************************** |
| Cardiac mass QTL 12 | 1 | ****************************** |
| Collagen induced arthritis QTL 10 | 1 | ****************************** |
| Despair related QTL 8 | 1 | ****************************** |
| Blood pressure QTL 193 | 1 | ****************************** |
| Saccharin preference QTL 2 | 1 | ****************************** |
| Blood pressure QTL 60 | 1 | ****************************** |
| Brain ventricular dilatation QTL 7 | 1 | ****************************** |
| Blood pressure QTL 187 | 1 | ****************************** |
| Saccharin preference QTL 7 | 1 | ****************************** |
| Stress response QTL 6 | 1 | ****************************** |
| Cardiac cell morphology QTL 1 | 1 | ****************************** |
| Pristane induced arthritis QTL 16 | 1 | ****************************** |
| Blood pressure QTL cluster 4 | 1 | ****************************** |
| Cardiac mass QTL 41 | 1 | ****************************** |
| Kidney mass QTL 5 | 1 | ****************************** |
| Blood pressure QTL 139 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 22 | 1 | ****************************** |
| Body weight QTL 39 | 1 | ****************************** |
| Blood pressure QTL 223 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 55 | 1 | ****************************** |
| Blood pressure QTL 58 | 1 | ****************************** |
| Blood pressure QTL 267 | 1 | ****************************** |
| Body weight QTL 26 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 5 | 1 | ****************************** |
| Blood pressure QTL 80 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 7 | 1 | ****************************** |
| Renal function QTL 34 | 1 | ****************************** |
| Blood pressure QTL 146 | 1 | ****************************** |
| Body weight QTL2 | 1 | ****************************** |
| Bone mineral density QTL 2 | 1 | ****************************** |
| CD45RC expression in CD8 T cells QTL 2 | 1 | ****************************** |
| Urinary albumin excretion QTL 25 | 1 | ****************************** |
| Collagen induced arthritis QTL 20 | 1 | ****************************** |
| Blood pressure QTL 22 | 1 | ****************************** |
| Proteinuria QTL 5 | 1 | ****************************** |
| Renal function QTL 45 | 1 | ****************************** |
| Urinary albumin excretion QTL 27 | 1 | ****************************** |
| Cardiac mass QTL 26 | 1 | ****************************** |
| Blood pressure QTL 39 | 1 | ****************************** |
| Proteinuria QTL 4 | 1 | ****************************** |
| Cardiac mass QTL 30 | 1 | ****************************** |
| Anxiety related response QTL 14 | 1 | ****************************** |
| Pristane induced arthritis QTL 11 | 1 | ****************************** |
| Blood pressure QTL 47 | 1 | ****************************** |
| Cardiac mass QTL 46 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 2 | 1 | ****************************** |
| Anxiety related response QTL 13 | 1 | ****************************** |
| Cardiac mass QTL 51 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 5 | 1 | ****************************** |
| Bone mineral density QTL 6 | 1 | ****************************** |
| Aortic elastin QTL 3 | 1 | ****************************** |
| Alcohol consumption QTL 14 | 1 | ****************************** |
| Vascular elastic tissue fragility QTL 1 | 1 | ****************************** |
| Collagen induced arthritis QTL 17 | 1 | ****************************** |
| Vascular neointimal growth QTL 1 | 1 | ****************************** |
| Serum renin concentration QTL 6 | 1 | ****************************** |
| Blood pressure QTL 164 | 1 | ****************************** |
| Blood pressure QTL 92 | 1 | ****************************** |
| CIA Autoantibody QTL 2 | 1 | ****************************** |
| Hepatic cholesterol level QTL 1 | 1 | ****************************** |
| Oil induced arthritis QTL 8 | 1 | ****************************** |
| Cardiac mass QTL 7 | 1 | ****************************** |
| Adjuvant induced arthritis QTL 3 | 1 | ****************************** |
| Spike wave discharge measurement QTL 2 | 1 | ****************************** |
| Heart rate QTL 5 | 1 | ****************************** |
| Blood pressure QTL 115 | 1 | ****************************** |
| Collagen induced arthritis QTL 12 | 1 | ****************************** |
| Blood pressure QTL 239 | 1 | ****************************** |
| Blood pressure QTL 182 | 1 | ****************************** |
| Saccharin preference QTL 3 | 1 | ****************************** |
| Blood pressure QTL 61 | 1 | ****************************** |
| Serum leptin concentration QTL 2 | 1 | ****************************** |
| Blood pressure QTL 192 | 1 | ****************************** |
| Blood pressure QTL 143 | 1 | ****************************** |
| Mammary carcinoma susceptibility modifier QTL 1 | 1 | ****************************** |
| Blood pressure QTL 255 | 1 | ****************************** |
| Renal function QTL 15 | 1 | ****************************** |
| Pristane induced arthritis QTL 17 | 1 | ****************************** |
| Blood pressure QTL cluster 5 | 1 | ****************************** |
| Blood pressure QTL 266 | 1 | ****************************** |
| Body weight QTL 14 | 1 | ****************************** |
| Acute phase response QTL 4 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 23 | 1 | ****************************** |
| Glucose level QTL 6 | 1 | ****************************** |
| Blood pressure QTL 212 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 56 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL 4 | 1 | ****************************** |
| Blood pressure QTL 232 | 1 | ****************************** |
| Urinary albumin excretion QTL 12 | 1 | ****************************** |
| Blood pressure QTL 79 | 1 | ****************************** |
| Bone structure and strength QTL 2 | 1 | ****************************** |
| CD45RC expression in CD8 T cells QTL 1 | 1 | ****************************** |
| Thymus enlargement suppressive QTL 1 | 1 | ****************************** |
| Body weight QTL3 | 1 | ****************************** |
| Bone mineral density QTL 1 | 1 | ****************************** |
| Serum cholesterol QTL 26 | 1 | ****************************** |
| Urinary albumin excretion QTL 21 | 1 | ****************************** |
| Collagen induced arthritis QTL 21 | 1 | ****************************** |
| Blood pressure QTL 23 | 1 | ****************************** |
| Proteinuria QTL 6 | 1 | ****************************** |
| Renal function QTL 37 | 1 | ****************************** |
| Urinary albumin excretion QTL 24 | 1 | ****************************** |
| Blood pressure QTL 102 | 1 | ****************************** |
| Experimental allergic encephalomyelitis QTL y | 1 | ****************************** |
| Tongue tumor susceptibility QTL 10 | 1 | ****************************** |
| Cardiac mass QTL 29 | 1 | ****************************** |
| Anxiety related response QTL 7 | 1 | ****************************** |
| Blood pressure QTL 73 | 1 | ****************************** |
| Blood pressure QTL 48 | 1 | ****************************** |
| Smooth muscle cell number QTL 1 | 1 | ****************************** |
| Estrogen-induced mammary cancer QTL 1 | 1 | ****************************** |
| Alcohol consumption QTL 17 | 1 | ****************************** |
| Liver neoplastic nodule remodeling QTL 2 | 1 | ****************************** |
| Streptococcal cell wall induced arthritis QTL 1 | 1 | ****************************** |
| Bone mineral density QTL 7 | 1 | ****************************** |
| Serum corticosterone level QTL 1 | 1 | ****************************** |
| Hepatocarcinoma susceptibility QTL 5 | 1 | ****************************** |
| Vascular elastic tissue fragility QTL 2 | 1 | ****************************** |
| Collagen induced arthritis QTL 19 | 1 | ****************************** |
| Bone structure and strength QTL 21 | 1 | ****************************** |
| Body weight QTL 29 | 1 | ****************************** |
| Serum cholesterol level QTL 17 | 1 | ****************************** |
| Blood pressure QTL 93 | 1 | ****************************** |
| CIA Autoantibody QTL 3 | 1 | ****************************** |
| Cardiac mass QTL 32 | 1 | ****************************** |
| Cardiac mass QTL 1 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 1 | 1 | ****************************** |
| Adjuvant induced arthritis QTL 4 | 1 | ****************************** |
| Serum cholesterol level QTL 29 | 1 | ****************************** |
| Heart rate QTL 8 | 1 | ****************************** |
| Blood pressure QTL 116 | 1 | ****************************** |
| Serum cholesterol level QTL 1 | 1 | ****************************** |
| Kidney mass QTL 17 | 1 | ****************************** |
| Renal function QTL 24 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 33 | 1 | ****************************** |
| Body weight QTL 18 | 1 | ****************************** |
| Serum triglyceride level QTL 10 | 1 | ****************************** |
| Cardiac mass QTL 6 | 1 | ****************************** |
| Non-insulin dependent diabetes mellitus QTL 43 | 1 | ****************************** |
| X-ray hypersensitivity QTL 1 | 1 | ****************************** |
| Kidney mass QTL 23 | 1 | ****************************** |
| Renal function QTL 9 | 1 | ****************************** |
| Pristane induced arthritis QTL 18 | 1 | ****************************** |
| Mammary carcinoma susceptibility QTL 7 | 1 | ****************************** |
| Stress response QTL 7 | 1 | ****************************** |
| Collagen induced arthritis QTL 27 | 1 | ****************************** |
| Acute phase response QTL 6 | 1 | ****************************** |
| Cardiac mass QTL 15 | 1 | ****************************** |
| Glucose level QTL 3 | 1 | ****************************** |
| Blood pressure QTL 208 | 1 | ****************************** |
| Thymus enlargement QTL 3 | 1 | ****************************** |
| Blood pressure QTL 71 | 1 | ****************************** |
| Stress response QTL 10 | 1 | ****************************** |
| Blood pressure QTL 228 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 6 | 1 | ****************************** |
| Renal disease susceptibility QTL 3 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 15 | 1 | ****************************** |
| Blood pressure QTL 207 | 1 | ****************************** |
| Urinary albumin excretion QTL 2 | 1 | ****************************** |
| Body weight QTL4 | 1 | ****************************** |
| Bone mineral density QTL 3 | 1 | ****************************** |
| Blood pressure QTL 226 | 1 | ****************************** |
| Mammary tumor resistance QTL 2 | 1 | ****************************** |
| Collagen induced arthritis QTL 22 | 1 | ****************************** |
| Blood pressure QTL 24 | 1 | ****************************** |
| Tongue tumor susceptibility QTL 9 | 1 | ****************************** |
| Blood pressure QTL 201 | 1 | ****************************** |
| Pristane induced arthritis QTL 20 | 1 | ****************************** |
| Cardiac mass QTL 27 | 1 | ****************************** |
| Oil induced arthritis QTL 3 | 1 | ****************************** |
| Cardiac mass QTL 52 | 1 | ****************************** |
| Blood pressure QTL 229 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 14 | 1 | ****************************** |
| Pristane induced arthritis QTL 12 | 1 | ****************************** |
| Blood pressure QTL 49 | 1 | ****************************** |
| Cardiac mass QTL 48 | 1 | ****************************** |
| Estrogen-induced pituitary tumorigenesis QTL 9 | 1 | ****************************** |
| Saccharine consumption QTL 5 | 1 | ****************************** |
| Oil induced arthritis QTL 4 | 1 | ****************************** |
| Serum cholesterol level QTL 12 | 1 | ****************************** |
| Bone mineral density QTL 15 | 1 | ****************************** |
| Blood pressure QTL 247 | 1 | ****************************** |
| Anxiety related response QTL 6 | 1 | ****************************** |
| Blood pressure QTL 131 | 1 | ****************************** |
| Collagen induced arthritis QTL 1 | 1 | ****************************** |
| Bone mineral density QTL 14 | 1 | ****************************** |
| Saline consumption QTL 2 | 1 | ****************************** |
| Blood pressure QTL 166 | 1 | ****************************** |
| Blood pressure QTL 94 | 1 | ****************************** |
| CIA Autoantibody QTL 4 | 1 | ****************************** |
| Despair related QTL 12 | 1 | ****************************** |
| Aerobic running capacity QTL 3 | 1 | ****************************** |
| Hepatocarcinoma resistance QTL 2 | 1 | ****************************** |
| Blood pressure QTL 29 | 1 | ****************************** |
US Server